HK Stock MarketDetailed Quotes

09877 JENSCARE-B

Watchlist
  • 5.410
  • -2.900-34.90%
Market Closed Mar 28 16:08 CST
2.26BMarket Cap-5503P/E (TTM)

About JENSCARE-B Company

Ningbo Jianshi Technology Co., Ltd. is a medical device company based in China, dedicated to developing interventional products for the treatment of structural heart disease. The company was established in November 2011 in China. Since then, we have developed a range of treatment solutions for different types of structural heart diseases, including tricuspid valve disease, aortic valve disease, mitral valve disease, and heart failure. Our core product, LUX-Valve, has the potential to treat severe tricuspid valve reflux, and according to Frost & Sullivan's data, since LUX-Valve is the world's first product under development to complete the enrollment of test subjects in confirmatory clinical trials, it is expected to be one of the first transcatheter tricuspid valve replacement products approved for commercialization in the world. Furthermore, according to Frost & Sullivan's data, LUX-Valve was recognized as a “breakthrough medical device” under the Breakthrough Medical Device Program by the US Food and Drug Administration in November 2021, making it the first domestic self-developed medical device in the field of valvular heart disease treatment to receive this certification. Our other core product, Ken-Valve, is designed to treat severe aortic valve reflux (or aortic stenosis combined with aortic stenosis) and is expected to meet the needs of more patients, far greater than the transcatheter aortic valve replacement system for which only treatment of aortic stenosis is indicated. We are also developing eight other products with advanced technology, including (i) JenSclip, an innovative transcatheter mitral valve repair clamping system with many unique designs that make it stand out from other transcatheter mitral valve repair systems on the market; (ii) MitraPatch, an innovative transcatheter mitral valve repair product that uses valve repair technology to repair the mitral valve; and a number of advanced products under development for different types of valvular heart disease and heart failure.

Company Profile

Symbol09877
Company NameJENSCARE-B
ISINCNE100005KC9
Listing Date10/10/2022
Issue Price27.80
Shares Offered8.08M share
Founded11/08/2011
RegistrationChina
ChairmanShiwen Lv
SecretaryYuanyuan\huangweichao Li
Audit InstitutionErnst & Young
Company CategoryMainland registration of Mainland Individuals control
Registered OfficeBuilding 5, Area B, 777 Binhai 4th Road, Hangzhou Bay New District, Ningbo, Zhejiang, China
Head Office and Principal Place of Business40th Floor, Dah Sing Financial Centre, 248 Queen's Road East, Wan Chai, Hong Kong
Fiscal Year Ends12-31
Employees376
MarketHong Kong motherboard
Phone(0574)63935666
Fax(86574)63935666
Emailinfo@jenscare.com
Business Ningbo Jianshi Technology Co., Ltd. is a Chinese company mainly engaged in the manufacture and development of medical devices. The company is dedicated to developing interventional products for the treatment of structural heart disease. The company's core products include LUX-Valve and Ken-Valve. LUX-Valve is a transcatheter tricuspid valve replacement system designed for patients with severe tricuspid valve reflux and high surgical risk. Ken-Valve is designed to treat severe aortic valve reflux or aortic stenosis. The company is also developing research products for the treatment of mitral valve disease and medical devices for the treatment of heart failure. The company mainly operates in the domestic market of China.

Company Executives

  • Name
  • Position
  • Salary
  • Shiwen Lv
  • chief technology officer,Executive Director,Remuneration and Assessment Committee Members,Authorized Representative,Chairman of the Board,CEO,Strategy Committee Chairman,Nomination Committee Member
  • --
  • Fei Pan
  • Executive Director, Chief Financial Officer, Secretary of the Board of Directors, Authorized Representative,Member of the Strategy Committee
  • --
  • TAN Ching
  • Non-Executive Director
  • --
  • Jiaqi Zheng
  • Non-Executive Director
  • --
  • Youpei Xie
  • Non-Executive Director
  • --
  • Xinxing Chen
  • Non-Executive Director
  • --
  • Shoukang Lin
  • Strategy Committee Member,Nomination Committee Chairman,Audit Committee Member,Chairman of the Remuneration and Assessment Committee,Independent Non-Executive Director
  • --
  • Jiliu Du
  • Audit Committee Chairman,Independent Non-Executive Director,Remuneration and Assessment Committee Members
  • --
  • Lehe Mei
  • Nomination Committee Member,Independent Non-Executive Director,Audit Committee Member
  • --
  • Jing Xu
  • Chairman of the Supervisory Board
  • --
  • Hao Tang
  • Supervisor
  • --
  • Bo Hu
  • Supervisor
  • --
  • Yibin Li
  • VP
  • --
  • Biao Li
  • VP
  • --
  • Ruinian Zhang
  • VP
  • --
  • Yuanyuan Li
  • Director of Finance,Joint Company Secretary
  • --
  • Weichao Huang
  • Joint Company Secretary
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg